|
Market Closed -
OTC Markets
15:50:25 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.0300 USD | +7.14% |
|
-18.92% | +15.38% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAP.Y 0.0300 $
+7.14%
2.32K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAP.Y | 0.0300USD | +7.14% | 2.32K $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 2026-10-05 | 2026-10-06 | 2026-10-07 | 2026-10-08 | 2026-10-09 | |
|---|---|---|---|---|---|
| Last | US$0.0300 | US$0.0290 | US$0.0279 | US$0.0280 | US$0.0300 |
| Volume | 221,406 | 281,986 | 136,960 | 50,878 | 77,399 |
| Change | -18.92% | -3.33% | -3.79% | +0.36% | +7.14% |
| Opening | US$0.0200 | US$0.0211 | US$0.0219 | US$0.0221 | US$0.0256 |
| High | US$0.0370 | US$0.0300 | US$0.0289 | US$0.0280 | US$0.0320 |
| Low | US$0.0200 | US$0.0211 | US$0.0200 | US$0.0220 | US$0.0256 |
Performance
| 1 day | +7.14% | ||
| 1 week | -18.92% | ||
| Current month | -21.05% | ||
| 1 month | +32.45% | ||
| 3 months | -9.09% | ||
| 6 months | +50.00% | ||
| Current year | +15.38% | ||
| 1 year | -83.78% | ||
| 3 years | -95.59% | ||
| 5 years | -99.42% | ||
| 10 years | -99.54% |
Volumes
marketsDaily volume
77,399
Estimated daily volume
77,399
Avg. Volume 20 sessions
255,086
Daily volume ratio
0.3
Avg. Volume 20 sessions USD
7,652.58
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
7,951,547
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03%
Free-Float capitalization (USD)
6,691,324
Average Daily Capital Traded
0.1%
Indicators
Moving average 5 days
0.029
Moving average 20 days
0.0275
Moving average 50 days
0.0276
Moving average 100 days
0.0288
Price spread / (MMA5)
-3.33%
Price spread / (MMA20)
-8.33%
Price spread / (MMA50)
-8.00%
Price spread / (MMA100)
-4.00%
STIM
RSI 9 days
47.45
RSI 14 days
49.44
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.14% | -18.92% | -83.78% | -95.59% | 7.95M | |
| +0.83% | +3.19% | +41.49% | +94.83% | 1,051B | |
| +1.93% | +2.11% | +37.08% | +67.40% | 630B | |
| +1.49% | +5.19% | +19.94% | +85.13% | 489B | |
| +2.26% | +0.90% | +69.32% | +40.73% | 359B | |
| +1.45% | +3.50% | +23.29% | +40.84% | 344B | |
| +1.17% | +2.37% | +13.47% | +32.81% | 272B | |
| +0.89% | +1.08% | -6.13% | +9.63% | 246B | |
| +1.82% | +2.94% | +42.99% | +46.29% | 224B | |
| +2.77% | +4.44% | +29.01% | +96.43% | 187B | |
| Average | +2.18% | +0.68% | +18.67% | +41.85% | 380.37B | |
| Weighted average by Cap. | +1.47% | +2.93% | +33.36% | +66.30% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
ca23bc56587a4759ef6a9b97730.mpbCg_ZYDZmjaWiKXnqSEVI25_w_GyXgpIJJXjxYVkM.7feqxY80Ze70EV3yMxv6TmsAioVcQXKSyOM9Cg8aYBD50oWxwiBE6O4oLQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 15:50:25 | 0.0300 | 100 | 77,111 |
| 15:41:09 | 0.0284 | 396 | 77,011 |
| 15:38:56 | 0.0269 | 136 | 76,615 |
| 15:34:47 | 0.0269 | 1,300 | 76,479 |
| 15:19:43 | 0.0300 | 100 | 75,179 |
| 15:07:03 | 0.0269 | 9,649 | 75,079 |
| 15:06:54 | 0.0269 | 3,997 | 65,430 |
| 14:10:38 | 0.0300 | 100 | 61,433 |
| 14:08:55 | 0.0300 | 6,250 | 61,333 |
| 13:57:53 | 0.0300 | 898 | 55,083 |
Price Extremes
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0 | | 0.04 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.24 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 5.95 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | +15.38% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAP.Y Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
